Skip to main content
NIH Intramural Research Program, Our Research Changes Lives

Navigation controls

  • Search
  • Menu

Social follow links

  • Podcast
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
      • Nobel Prize
      • Lasker Award
      • Breakthrough Prize
      • Shaw Prize
      • Presidential Early Career Award for Scientists and Engineers (PECASE)
      • Presidential Medal of Freedom
      • National Medal of Science
      • Searle Scholars
      • The National Academy of Sciences
      • The National Academy of Medicine
      • The National Academy of Engineering
      • The American Academy of Arts and Sciences
      • National Medal of Technology & Innovation
      • Samuel J. Heyman Service to America Medals
      • Crafoord Prize
      • Fellows of the Royal Society
      • Canada Gairdner Awards
    • Organization & Leadership
    • Our Programs
      • NCI
      • NEI
      • NHGRI
      • NHLBI
      • NIA
      • NIAAA
      • NIAID
      • NIAMS
      • NIBIB
      • NICHD
      • NIDA
      • NIDCD
      • NIDCR
      • NIDDK
      • NIEHS
      • NIMH
      • NIMHD
      • NINDS
      • NINR
      • NLM
      • CC
      • NCATS
      • NCCIH
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
      • Biomedical Engineering & Biophysics
      • Cancer Biology
      • Cell Biology
      • Chemical Biology
      • Chromosome Biology
      • Clinical Research
      • Computational Biology
      • Developmental Biology
      • Epidemiology
      • Genetics & Genomics
      • Health Disparities
      • Immunology
      • Microbiology & Infectious Diseases
      • Molecular Biology & Biochemistry
      • Molecular Pharmacology
      • Neuroscience
      • RNA Biology
      • Social & Behavioral Sciences
      • Stem Cell Biology
      • Structural Biology
      • Systems Biology
      • Virology
    • Principal Investigators
      • View by Investigator Name
      • View by Scientific Focus Area
    • Accomplishments
      • View All Accomplishments by Date
      • View All Health Topics
      • The Body
      • Health & Wellness
      • Conditions & Diseases
      • Procedures
    • Accelerating Science
      • Investing in Cutting-Edge Animal Models
      • Creating Cell-Based Therapies
      • Advancing Computational and Structural Biology
      • Combating Drug Resistance
      • Developing Novel Imaging Techniques
      • Charting the Pathways of Inflammation
      • Zooming in on the Microbiome
      • Uncovering New Opportunities for Natural Products
      • Stimulating Neuroscience Research
      • Pursuing Precision Medicine
      • Unlocking the Potential of RNA Biology and Therapeutics
      • Producing Novel Vaccines
    • Research in Action
      • View All Stories
      • Battling Blood-Sucking Bugs
      • Unexpected Leads to Curb Addiction
      • Shaping Therapies for Sickle Cell Disease
      • The Mind’s Map Maker
    • Trans-IRP Research Resources
      • Supercomputing
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
      • Get Involved with Clinical Research
      • Physician Resources
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
      • Stadtman Tenure-Track Investigators
        • Science, the Stadtman Way
      • Lasker Clinical Research Scholars
      • Independent Research Scholar
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
I am Intramural Blog

Delivering on Maternal Health

IRP’s Katherine Grantz Develops Tools to Predict Pregnancy Complications

By Melissa Glim

Tuesday, January 23, 2024

pregnant woman in hospital

Fetal growth can indicate how well a pregnancy is progressing and help inform timing of delivery, making it a crucial indicator for the research of IRP senior investigator Katherine Grantz.

Advancements in medicine have reduced the risk of childbearing dramatically, but rates of maternal death have been creeping up in recent years. The reasons are varied. Older first-time parents, greater health concerns like obesity and hypertension, and lack of access to maternity care are important factors.

In observance of Maternal Health Awareness Day on January 23, we spoke with Katherine Grantz, M.D., a maternal-fetal medicine specialist and senior investigator at the Eunice Kennedy Shriver National Institute on Child Health and Human Development (NICHD). She is trying to improve health for pregnant people and their babies experiencing complications like gestational diabetes and hypertension, as well as reduce preterm deliveries and unnecessary C-sections.

“With increasing weight and maternal age, there’s a subsequent increase in a lot of pregnancy-related disease and pregnancy-specific complications,” says Dr. Grantz.

Fetal growth is an important indicator for how well a pregnancy is progressing and guides clinical management decisions from nutrition to disease treatment to determining the best time for delivery. A very small fetus may indicate health problems such as high blood pressure, malnutrition, or other complications that could result in a stillbirth or illness. Meanwhile, a very large fetus may indicate health problems for both mother and baby, such as gestational diabetes, and could lead to injuries at birth. Knowing what to expect helps medical professionals and expecting parents make appropriate choices and prepare for any complications during delivery and after.

“I'm very interested in the timing of delivery for pregnancy,” Dr. Grantz says. “Fetal growth is important in part, because it is related to timing of natural delivery and helps to inform delivery planning when the pregnancy is complicated by abnormal growth. Right now, there’s some debate over the optimal time to deliver these pregnancies for best results.”

Dr. Katherine Laughon Grantz

Dr. Katherine Grantz

That’s because making that determination has always been more of an art than a science. Reliable, standard growth charts based on a large, diverse group of pregnant people didn’t exist for developing fetuses until 2015 when researchers at NICHD completed the first large-scale study of 2,334 pregnant women from diverse communities in the U.S.1,2 Before then, multiple charts based on small studies were available, but they varied among clinics, causing confusion. One clinic might determine a fetus is in the 9th percentile of growth, meaning it is undersized, and then refer the mother to a specialist where a different chart indicates the fetus is within the normal growth range.

Diversity was another issue with the older charts. The most common fetal growth reference used in the U.S. — the Hadlock reference — was based on a study of 392 Caucasian patients from Texas. In contrast, NICHD has conducted multiple sub-studies of women from multiple racial and ethnic backgrounds. This studies included women with complications like gestational diabetes and who gave birth to twins, which offers a more refined understanding of fetal growth among pregnancies.3

In addition to a more reliable and uniform growth chart, Dr. Grantz and her team has developed a second tool that helps determine how fast a fetus is growing, known as its 'fetal velocity.'

“It's typical to identify abnormal fetal growth using a one-time measurement,” Dr. Grantz says. “For example, if the estimated fetal weight is less than the 10th percentile, then the pregnancy might be flagged as undersized, or if it's greater than the 90th percentile, it can be flagged as being large for gestational age.”

The problem with using one measurement in time is that it can be difficult to distinguish between babies that are growing abnormally due to a health issue and babies that are healthy, but just happen to be bigger or smaller than average. Likewise, a single measurement can miss an abnormally growing fetus if it is on the borderline of what’s considered normal. However, if the rate of growth is slowing down or speeding up, doctors can determine if the size is truly indicative of a serious problem.

"Our studies suggest that if you add in velocity of fetal growth, it decreases the error in predicting birth weight,” Dr. Grantz says

timeline of the growth of a fetus in the womb

Dr. Grantz’s research focuses on 'fetal velocity,' or how fast a fetus is growing, to identify pregnancies that might be at higher risk for health complications.

“I've always had a keen interest in providing data to fill in data gaps regarding clinical guidelines and obstetrics,” Dr. Grantz says of her work. In the past, pregnant people were often excluded from clinical trials and research due to safety concerns, but their omission came with the absence of data to guide clinical management. Now that the field is better balancing the risks of fetal harm with the potential health benefits to the mother and child, Dr. Grantz says they can begin to address many unanswered questions.

“Questions such as when to induce delivery in patients with high blood pressure or diabetes are common, but very challenging,” she adds. “That's what I'm trying to tackle: to see if we can provide data to help inform guidelines and answer these difficult-to-answer but important questions.”

Subscribe to our weekly newsletter to stay up-to-date on the latest breakthroughs in the NIH Intramural Research Program.

References:

[1] Grantz KL, Grewal J, Kim S, Grobman WA, Newman RB, Owen J, Sciscione A, Skupski D, Chien EK, Wing DA, Wapner RJ, Ranzini AC, Nageotte MP, Craigo S, Hinkle SN, D’Alton ME, He D, Tekola-Ayele F, Hediger ML, Buck Louis GM, Zhang C, Albert PS. Unified standard for fetal growth: the Eunice Kennedy Shriver National Institute of Child Health and Human Development Fetal Growth Studies. Am J Obstet Gynecol. 2022 Apr;226(4):576-587. doi: 10.1016/j.ajog.2021.12.006.

[2] Grantz KL, Grewal J, Kim S, Grobman WA, Newman RB, Owen J, Sciscione A, Skupski D, Chien EK, Wing DA, Wapner RJ, Ranzini AC, Nageotte MP, Craigo S, Hinkle SN, D'Alton ME, He D, Tekola-Ayele F, Hediger ML, Buck Louis GM, Zhang C, Albert PS. Unified standard for fetal growth velocity: the Eunice Kennedy Shriver National Institute of Child Health and Human Development Fetal Growth Studies.(external link) Am J Obstet Gynecol. 2022;227(6):916-922.e1.

[3] Grantz KL, Hediger ML, Liu D, Buck Louis GM. Fetal growth standards: the NICHD fetal growth study approach in context with INTERGROWTH-21st and the World Health Organization Multicentre Growth Reference Study. Am J Obstet Gynecol. 2018 Feb;218(2S):S641-S655. e28.2017.11.593. doi: 10.1016/j.ajog.


Category: IRP Discoveries
Tags: women's health, women in science, pregnancy, epidemiology

Related Blog Posts

  • Blood Test Predicts Premature Labor
  • Unlocking the Genetic Mysteries of Rare Autoinflammatory Diseases
  • Comparing Two Ways to Blast Tumors
  • The Heartache of Discrimination
  • Cooking Up a Recipe for Healthier Eating

This page was last updated on Tuesday, January 23, 2024

Blog menu

  • Contributing Authors
    • Anindita Ray
    • Brandon Levy
    • Devon Valera
    • Melissa Glim
  • Categories
    • IRP Discoveries
    • Profiles
    • Events
    • NIH History
    • IRP Life

Blog links

  • Subscribe to RSS feed

Get IRP Updates

Subscribe

  • Email
  • Print
  • Share Twitter Facebook LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
    • Organization & Leadership
    • Our Programs
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
    • Principal Investigators
    • Accomplishments
    • Accelerating Science
    • Research in Action
    • Trans-IRP Research Resources
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
  • Department of Health and Human Services
  • National Institutes of Health
  • USA.gov

Footer

  • Home
  • Contact Us
  • IRP Brand Materials
  • HHS Vulnerability Disclosure
  • Web Policies & Notices
  • Site Map
  • Search